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Previously we reported that null mutant viruses of UL19 (VP5) or of UL18 (VP23), essential components of herpes simplex
virus type 1 (HSV-1) capsid shells, do not form precursor capsid structures as judged by sedimentation and electron
microscope analysis. A goal of the present experiments was to isolate a null mutant virus for the remaining essential
component of capsid shells, VP19C, encoded by the UL38 open reading frame (ORF). Furthermore, we wished to determine
if a virus altered in the UL26 maturation cleavage site at residues 610 and 611 produced a lethal phenotype. Therefore, we
decided to isolate cell lines that encode and express multiple capsid genes. Several cell lines were isolated by transformation
of Vero cells and one designated C32 expressed all of the essential capsid proteins. Using this cell line we isolated a null
mutant virus in the UL38 ORF and a mutant virus that was altered at residues 610 and 611 of the UL26 and UL26.5 gene
products. We found that the null mutant in VP19C did not form a detectable product as judged by sedimentation and electron
microscope analyses following infection of nonpermissive cells. The mutant virus altered at the UL26 maturation site resulted
in the accumulation of B capsids. Therefore, cleavage at this site was essential for the maturation of B capsids into C capsids.
Interestingly, the absence of cleavage at the maturation site was required for the retention of VP24 in the capsid. © 1998
Academic Press
INTRODUCTION
The herpes simplex virus type 1 (HSV-1) B capsid is
composed predominantly of seven capsid proteins.
Their designation, and the open reading frames (ORF)
encoding the proteins, are VP5 (UL19), VP19C (UL38),
21 (UL26), 22a (UL26.5), VP23 (UL18), VP24 (UL26), and
VP26 (UL35) (Gibson and Roizman, 1972; Heilman et
al., 1979; Cohen et al., 1980; McGeoch et al., 1988).
VP5, the major capsid protein, in association with
scaffold molecules (the more abundant 22a and prob-
ably the less abundant 21), forms the 150 hexons and
12 pentons present in capsid shells (Newcomb et al.,
1989, 1993; Booy et al., 1991; Zhou et al., 1994). Adja-
cent pentons and hexons are held together, at least in
part, by a complex of VP19C and VP23, referred to as
the triplex because of its three-pronged structure in
cryoelectron micrographs (Newcomb et al., 1993; Zhou
et al., 1994; Trus et al., 1996). VP26 is located at the
outer surface of VP5 hexons, but not pentons (Booy et
al., 1994; Trus et al., 1995; Zhou et al., 1995). It is not
essential for capsid formation in mammalian cell cul-
ture (Desai et al., 1998), in insect cells that express all
of the capsid proteins except VP26, (Tatman et al.,
1994; Thomsen et al., 1994), or in capsids formed in
vitro from proteins expressed in insect cells (New-
comb et al., 1996). However, the absence of VP26 in
the virion results in a reduction in the number of
infectious viruses produced during replication in the
mouse trigeminal ganglia by 30- to 100-fold (Desai et
al., 1998).
Three of the B capsid proteins are encoded by the
UL26 and UL26.5 ORFs from two 39 coterminal tran-
scripts (Holland et al., 1984; Liu and Roizman, 1991a).
One transcript, designated UL26, is initiated 180 nucle-
otides upstream of the entire coding sequence, and the
second, designated UL26.5, is initiated near the center of
the ORF (1000 nucleotides downstream of the first tran-
script). The UL26 ORF (635 amino acid residues) en-
codes a protease (Liu and Roizman, 1991b; Preston et al.,
1992) and cleavage occurs at two sites, a maturation site
between amino acid residues 610 and 611 and a release
site between residues 247 and 248 (Dilanni et al., 1993).
The proteolytic activity specified by UL26 has been lo-
calized to the N-terminal 247 residues (Liu and Roizman,
1993; Weinheimer et al., 1993). The products of the re-
lease site cleavage generate B capsid proteins VP24 and
21 (at the N-terminus and C-terminus, respectively)
(Weinheimer et al., 1993). The more abundant 22a is
encoded by the UL26.5 transcript and is initiated at
codon 307 (Liu and Roizman, 1991a,b). Therefore, 21 and
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22a are identical in amino acid sequence between res-
idues 307 and 635, and both proteins can specify scaf-
fold activity (Tatman et al., 1994; Thomsen et al., 1994;
Robertson et al., 1996). Throughout the text UL26 ORF
numbers will be used to designate residues in VP24, 21,
or 22a. Homologous proteins encoded by human and
simian cytomegalovirus (CMV) have been extensively
characterized by Gibson and his colleagues (see, for
example, Welch et al., 1991 and Gibson et al., 1994).
During the assembly of B capsids, interactions may
occur between VP5 monomers as well as between VP5
and each of the remaining capsid proteins. Cellular lo-
calization studies using fluorescently tagged antibodies
show that VP5 is transported into the nucleus more
efficiently in the presence of the precursor form of 22a
than in its absence and that VP5 and VP23 are trans-
ported efficiently in the presence of VP19C (Nicholson et
al., 1994; Rixon et al., 1996). Using the yeast two-hybrid
system interactions were detected between VP5 and
22a, a strong self-interaction among 22a proteins, and an
interaction between VP19C and VP23. Interactions be-
tween VP5 and 22a (encoded by UL26.5) were also
observed if the genes encoded by the UL26 ORF were
used (Desai and Person, 1996). The same interactions
were detected for the homologous proteins of human
CMV (Wood et al., 1997; Gibson et al., 1996). A major
self-interaction region of 22a included residues 457 to
504 of the UL26 ORF (Desai and Person, 1996), and
recently key residues within that region were identified
(Pelletier et al., 1997). The 25 amino acids C-terminal to
the maturation site specified by UL26 and UL26.5 are
necessary for interaction with VP5 (Thomsen et al., 1995;
Desai and Person, 1996; Hong et al., 1996). Capsid
shells, but not sealed capsids, are formed in the absence
of the C-terminal 25 amino acids of the UL26 and UL26.5
ORFs (Kennard et al., 1995; Matusick-Kumar et al., 1995;
Thomsen et al., 1995). For HSV-1 a minimal interaction
sequence was mapped to residues 622 to 633 using a
GST-pulldown assay (Hong et al., 1996). Furthermore,
residues 623 to 625 were shown to be sufficient deter-
minants to change the specificity of the reaction from
HSV-1 to HCMV (Beaudet-Miller et al., 1996). The inter-
action between the C-terminus of 22a and VP5 is en-
hanced by the self-interaction domain of 22a (Nicholson
et al., 1994; Pelletier et al., 1997). Although the region of
22a that interacts with VP5 has been extensively studied
the region of VP5 that interacts with 22a is not known.
Herpesviruses are unique in their capsid makeup in
having adjacent pentamers and hexamers of the major
capsid protein held together by a complex of two other
capsid and viral proteins, VP19C and VP23. VP19C–VP23
complexes have been observed in lysates of insect cells
that express these proteins (Spencer et al., 1998). In their
experiments the complex, but not the individual proteins,
bound to VP5 in the presence of scaffold molecules to
form capsids in vitro. The proteins of HCMV that are
homologous to VP19C and VP23 have also been de-
tected as a complex by coprecipitation and sedimenta-
tion techniques (Baxter and Gibson, 1998).
Several years ago we reported that a null mutation in
the gene encoding VP23 did not form capsids upon
infection of nonpermissive cells (Desai et al., 1993). Two
years ago we began to isolate a null mutant virus in the
gene encoding VP19C. At that time it was shown that
insect cells infected with baculoviruses that encode all of
the capsid proteins form an abundant amount of B cap-
sids (Tatman et al., 1994; Thomsen et al., 1994) and that
capsids were not formed if the virus encoding VP19C
(UL38) was omitted from the infection. Earlier, Pertuiset
et al. (1989) showed that a temperature-sensitive muta-
tion in UL38 did not give rise to capsids at the nonper-
missive temperature. Therefore it appeared that capsids
would not be assembled in a virus that lacked VP19C.
Nevertheless, we felt that the above observations
needed to be confirmed using a null mutant virus in the
UL38 gene. A cell line was also generated that was
transformed for all the genes specifying the essential
capsid proteins (UL18, UL19, UL26, and UL38). Such a
cell line is needed to construct multiple mutants in the
genes encoding these essential capsid proteins. This
cell line was capable of propagating mutants in the
genes encoding VP5, VP23, and UL26 and was used to
isolate the VP19C null mutant virus and a virus that was
blocked at the maturation cleavage site of UL26 (resi-
dues 610/611). The characterization of these mutant vi-
ruses is described below.
RESULTS
Isolation of cell lines that express multiple capsid
proteins
In order to isolate viruses that specify mutations in
more than one essential capsid gene, cell lines are
needed that express these genes. Since three relatively
small plasmids could be cloned that encode the essen-
tial capsid proteins (UL18, UL19, UL26, UL26.5, and
UL38) we decided to attempt to isolate a single cell line
that expressed all of the essential capsid proteins. Vero
cells were cotransformed with the three plasmids
(pKUL18-19, pKUL26, and pKUL38) and with pSV2neo at
molar ratios of four for each HSV-1 plasmid to one for
pSV2neo. Sixty-one neomycin-resistant colonies were
isolated and tested for the ability to support the growth of
null mutant viruses. Four supported the growth of mutant
viruses in UL18 (K23Z) and in UL19 (K5DZ) (Desai et al.,
1993). Three of these also supported the growth of the
null mutant virus in UL26 (KUL26DZ) (Desai et al., 1994),
and one of the three cell lines, designated C32, sup-
ported the growth of the UL38 temperature-sensitive
mutant A44ts2 at the nonpermissive temperature (Per-
tuiset et al., 1989). C32 was used to isolate a null mutant
virus in UL38 which encodes VP19C. The yield of mutant
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viruses in the other essential capsid genes (KD5Z, K23Z,
and KUL26DZ) was determined after a single cycle of
growth in C32 cells. Viruses were harvested 24 h after
infection at an m.o.i. of 10 PFU/cell using monolayer
cultures in six-well trays. The average yield was 1200
PFU/cell for KOS, 535 for KUL26DZ, and 455 for KD5Z and
K23Z.
Isolation and characterization of a virus specifying a
null mutation in the gene encoding VP19C
A mutant plasmid with a 1.26-kb deletion which in-
cluded almost all of the UL38 ORF was constructed from
pKUL38 as shown in Fig. 1. pKDUL38 was cotransfected
along with intact KOS DNA into C32 cells in a marker
transfer experiment. Infected cells were harvested and
titered 48 h later and approximately 30 PFU was added to
the same cells in 96-well trays. Wells were identified that
contained single plaques and viruses in these wells
were screened for growth on C32 and Vero cells. A virus
was found that grew on C32 but not on Vero cells. This
virus was plaque purified twice and a working stock of
virus was prepared on the permissive cells. The virus
was designated KD19C. Yields of approximately 50 PFU/
cell were obtained and the titer on permissive cells was
1 3 104 times that on Vero cells. Since the virus requires
a cell line that expresses VP19C for propagation, VP19C
is essential for viral growth in cell culture. This virus was
used in the studies described below. The low yield of 50
PFU/cell for the newly isolated KD19C virus was disap-
pointing and may be related to the fact that we were
isolating KD19C and the transformed cell lines at the
same time.
Southern blot analysis of the mutant virus DNA was
performed to determine the genotype of the virus in the
UL38 region of the KOS genome. Viral DNA was pre-
pared and cleaved with BamHI and SalI or with NcoI, and
the restriction fragments were separated by agarose gel
electrophoresis. Fragments were blotted onto nitrocellu-
lose and probed with radioactively labeled pKUL38 (Fig.
2). For KOS DNA cleaved with BamHI and SalI the probe
hybridized to the 3.9-kb fragment that encodes UL38 (Fig.
2, lane 1). For KD19C the probe hybridized to a single
fragment shortened by 1.26 kb (lane 2). Digestion of KOS
DNA with NcoI (see Fig. 1) gave three fragments (3.8, 2.2,
and 1.4 kb, see lane 3). For the mutant virus the 2.2-kb
fragment from the UL37 region was unaltered by the
deletion, while the two remaining fragments were fused
and shortened by 1.26 kb (lane 4). This analysis con-
firmed that the plasmid-specified mutation was intro-
duced into the virus genome. Furthermore, marker res-
cue experiments were carried out in C32 cells by co-
transfecting the cells with KD19C viral DNA and either
the pKUL38 plasmid or the control plasmid pKNot1
(UL26). The results from these experiments gave a
marker rescue frequency of the VP19C mutant of 8.2%
with pKUL38 and less than 1.1% with the control (pKNot1)
plasmid. This further confirmed the genotype of KD19C.
To investigate the synthesis of the VP19C polypeptide,
Vero and C32 cells were infected with KD19C and KOS
viruses at an m.o.i. of 10 PFU/cell. Infected cells were
FIG. 1. The UL38 region of the HSV-1 (KOS) genome. Restriction sites relevant to the current study are indicated in the top line. UL37, UL38, and
UL39 ORFs (McGeoch et al., 1988) are indicated in the second line. Sequences encoded by pKUL38 and the extent of the deletion in pKDUL38 are
also shown.
FIG. 2. Southern blot analysis of KD19C viral DNA. Viral DNA for KOS
(lanes 1 and 3) and for KD19C (lanes 2 and 4) was digested with BamHI
and SalI (lanes 1 and 2) or with NcoI (lanes 3 and 4) and the fragments
were resolved by agarose gel electrophoresis. Filters were probed with
32P-labeled pKUL38.
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harvested 24 h after infection and expression of VP19C
was assayed by Western blots (Fig. 3) using antibody
NC2 prepared to VP19C obtained from B capsids by Drs.
R. Eisenberg and G. Cohen. A band of radioactivity of the
appropriate size (50 kDa) was observed for nonpermis-
sive and permissive cells infected with wild-type virus
(Fig. 3, lanes 2 and 5, respectively) but is absent in
mutant-infected Vero cells (lane 3). A band, albeit of less
intensity, is also apparent for C32 cells infected with the
mutant virus (lane 6).
To determine if any precursor structures are formed in
KD19C infected nonpermissive cells, nuclear lysates ob-
tained from [35S]methionine-labeled infected Vero cells
were layered onto sucrose gradients and sedimented.
Fractions were collected and analyzed by SDS–PAGE
(Fig. 4). For KOS-infected cells (Fig. 4A), fractions con-
taining C (fraction 12), B (fraction 9), and predominantly A
(fraction 7) capsids were apparent. The positions of the
seven capsid proteins present in B capsids are shown
on the left side of the figure. A and C capsids lack the
scaffold proteins 22a and 21 and therefore are composed
of five proteins. DNA packaging results in the more
rapidly sedimenting C capsids. Since A and B capsids
were only partially resolved on these gradients some 22a
was present in fraction 7. Results obtained using KD19C
are shown in Fig. 4B. Neither the fractions corresponding
to A, B, or C capsids for KOS nor fractions closer to the
top of the gradient show any capsid sedimenting mate-
rial by this analysis.
Ultrastructural analysis of mutant-infected cells was
also performed to determine whether structures visible
by the electron microscope could be detected. Vero cells
were infected with KD19C and the nuclei in thin sections
examined by the electron microscope at 16 h postinfec-
tion (see Fig. 5A). No structures were detected in any of
the sections examined, confirming the data from the
sedimentation analysis.
Isolation and characterization of the UL26 maturation
cleavage site mutant virus
Since C32 cells expressed UL26 as well as UL38, a
virus specifying a mutation in the maturation cleavage
site of UL26 could be constructed to determine whether
cleavage at this site is essential for virus replication. To
construct the UL26 mutant virus we decided to alter the
residues at 610 and 611 of the UL26 and UL26.5 genes so
that the protease is not able to cleave at this site. Mu-
tations at these sites were introduced into a plasmid that
encoded the UL26 ORF using single-stranded DNA oli-
gonucleotide mutagenesis. The Ala–Ser-encoded resi-
dues were changed to Glu–Phe codons which also in-
troduced an EcoRI site. The mutation was transferred to
the KOS genome by homologous recombination. A mu-
tant virus, designated KUL26-610/611, was identified that
grew on C32 but not on Vero cells. Following plaque
purification a working stock was prepared on C32 cells
and samples of the stock were used in the following
experiments.
The presence and the location of the new EcoRI site in
KUL26-610/611 was confirmed by Southern blot analysis
(Fig. 6). The virus genome was probed with a 6.5-kb NotI
fragment that encodes UL26 (Desai et al., 1994). Cleav-
FIG. 4. Sedimentation analysis of nuclear lysates. Vero cells were
infected with KOS (A) and KD19C (B) at an m.o.i. of 10 PFU/cell and their
proteins were labeled from 8 to 24 h postinfection. Nuclear lysates
were sedimented through sucrose and the resulting fractions were
analyzed by SDS–PAGE (17% acrylamide). The direction of sedimenta-
tion was from left to right. Profiles representative of A (fraction 7), B
(fraction 9), and C (fraction 12) capsids were seen for KOS, but not for
the mutant virus. The positions of B capsid proteins are indicated on
the left of A.
FIG. 3. Western blot analysis of KD19C-infected cells. Vero (lanes 1
to 3) and C32 cells (lanes 4 to 6) were infected with KD19C (lanes 3 and
6) or KOS (lanes 2 and 5) or mock-infected (lanes 1 and 4) and
harvested 24 h postinfection, and infected cell proteins were separated
by SDS–PAGE (12% acrylamide). Proteins were electroblotted onto
filters and probed for the expression of VP19C using antibody NC2. The
amount of lysate loaded in lane 6 was 2.53 that loaded in lane 5. The
low reactivity of the antibody to VP19C observed in lane 4 is due to
overflow from lane 5.
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FIG. 5. Electron micrographs of thin sections of infected cell nuclei. Monolayers of Vero cells were infected with KD19C (A) and KUL26-610/611 (B)
at an m.o.i. of 10 PFU/cell. At 16 h postinfection, cells were fixed and processed for electron microscopy as described under Materials and Methods.
Original magnifications were 27,0003 for (A) and 54,0003 for (B). Electron-microscopy was carried out by Dr. Marco Chacon of Paragon Biotech, Johns
Hopkins Bayview Campus, Baltimore.
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age with NotI revealed a 6.5-kb band for mutant and KOS
DNA (Fig. 6, lanes 3 and 4). Cleavage with EcoRI gave
the 16.1-kb EcoRI wild-type fragment (lane 2) and two
fragments of 4.6 and 11.5 kb for the mutant DNA (lane 1).
When the two enzymes were used together the 6.5-kb
NotI fragment was cleaved into 3.5- and 3.0-kb fragments
in the case of the mutant virus (lane 5). This analysis
confirmed that the plasmid-specified mutation was intro-
duced into the virus genome; hence, the mutation at the
maturation site results in a lethal phenotype. Further-
more, marker rescue experiments were carried out in
C32 cells by cotransfecting the cells with KUL26-610/611
viral DNA and either the pKNot1 (UL26) plasmid or the
control plasmid pKUL38. The results from these experi-
ments gave a marker rescue frequency of the UL26
mutant of 12.7% with pKNot1 and less than 0.5% with the
control (pKUL38) plasmid. This further confirmed the ge-
notype of KUL26-610/611.
UL26 mutant viruses that encode an inactive protease
(Preston et al., 1992; Thomsen et al., 1995) or a null
mutant protease (Gao et al., 1994) assembled capsids
that were detected using electron microscopy and sed-
imentation analysis. To confirm that B capsids were
formed following infection of nonpermissive cells,
[35S]methionine-labeled nuclear lysates were prepared
and analyzed as in Fig. 4. For the mutant virus a single
peak of radioactivity was detected in the fractions con-
taining B capsids for wild-type infections. SDS–PAGE
analysis of the peak fractions are shown in Fig. 7 for KOS
and for KUL26-610/611 (lanes 3 and 4, respectively). The
positions of the B capsid proteins from KOS infections
are marked at the left of the figure. All of the proteins are
present and in similar quantities for capsids formed by
the mutant viruses, except VP24. Antibody precipitation
of the same sample with MCA406 (lanes 2 and 6), which
recognizes an internal region of the scaffold proteins,
shows that the proteins (21 and 22a) for KOS (lane 2) are
also present for KUL26-610/611 (lane 6) and are shifted to
lower mobility positions on the gel, consistent with the
absence of protease cleavage at the maturation site. To
analyze the relative amounts of precursor (uncleaved)
and mature (cleaved) species of scaffold proteins in the
capsids an antibody specific to the C-terminal 25 amino
acid residues (UL26-C) was used (lanes 1 and 5). Most of
the scaffold proteins in B capsids produced during KOS
infection were of the mature form since very little radio-
activity was detected (lane 1). By contrast a significant
amount of radioactivity was detected for capsids pro-
duced by the KUL26-610/611 mutant virus (lane 5). For
capsids from the mutant virus, no radioactivity was de-
tected at the mobility of the mature scaffold proteins
(compare lanes 2, 5, and 6).
Surprisingly, for the cleavage site mutant, little or no
radioactivity was detected at the mobility corresponding
to VP24 (residues 1 to 247). Protein 21 corresponding to
residues 248 to 635 of the UL26 ORF was present in
mutant capsids (Fig. 7, compare lanes 2 through 6).
FIG. 7. B capsids formed by KUL26-610/611. Vero cells were infected
with KOS (lanes 1 to 3) or with the mutant (lanes 4 to 6) and labeled with
[35S]methionine, and nuclear lysates sedimented through sucrose gra-
dients. Material from the single peak of radioactivity for KUL26-610/611
at the fraction corresponding to B capsids for KOS were examined by
SDS–PAGE (17% acrylamide) (lanes 3 and 4, respectively). Other sam-
ples from the same fractions were precipitated with antibodies specific
for the interior portion of the scaffold molecules, antisera MCA406
(lanes 2 and 6), or for the C-terminal 25 amino acids that are normally
removed by protease cleavage, antisera UL26-C (lanes 1 and 5). The
positions of B capsid proteins and of molecular weight markers (M) are
indicated. Shown below the gel is a figure of the two primary translation
products of the UL26 ORF, the protease cleavage sites at 247/248 and
610/611, and the recognition region for antibodies MCA406 and UL26-C.
FIG. 6. Southern blot analysis of KUL26-610/611 viral DNA. Viral DNA
of mutant (lanes 1, 3, and 5) and wild-type (lanes 2, 4, and 6) viruses
was digested with EcoRI (lanes 1 and 2), NotI (lanes 3 and 4), and with
both enzymes (lanes 5 and 6). The fragments were resolved by agarose
gel electrophoresis, transferred to filters, and probed with a radioac-
tively labeled NotI DNA fragment encoding the UL26 ORF.
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Western blot experiments were undertaken to confirm
that VP24 was synthesized in mutant virus infected cells.
Lysates were resolved by SDS–PAGE, along with a wild-
type virus sample of radioactively labeled B capsids (Fig.
8). After transfer to nitrocellulose filters the samples were
probed with an antibody specific to amino acids 8 to 14
of UL26. A band of radioactivity corresponding to the
mobility of VP24 in B capsids was detected for KOS (lane
2)- and mutant virus (lane 3)-infected cells. Cleavage of
the UL26 gene product between residues 247 and 248
appears to be normal for the mutant virus. A small
amount of radioactivity, probably corresponding to un-
cleaved translation product of the UL26 transcript, was
detected for the mutant virus (lane 3). The primary trans-
lation product was not visible for KOS infection, perhaps
due to a lower amount of radioactivity present in this
sample. We conclude that VP24 was synthesized in
KUL26-610/611 infections, but either was not incorpo-
rated into capsids or was incorporated and not retained
in capsids. Other experiments would be required to de-
termine if cleavage between residues 247 and 248 oc-
curred before or after its incorporation into capsids.
Electron microscope analysis of mutant-infected cells
was performed to determine the morphology of the B
capsids detected by sedimentation analysis above. Vero
cells were infected with KUL26-610/611 and the nuclei in
thin sections examined by electron microscopy at 16 h
postinfection. Capsids were detected in the nuclei of the
majority of the sections examined. The data presented in
Fig. 5B show a uniform population of capsids. The cap-
sids show an internal structure consistent with electron
scattering due to the presence of scaffold molecules, but
not the dark (electron-dense) central cores typical of C
capsids.
The first step in capsid growth is an interaction be-
tween VP5 and 22a and with the UL26 gene products.
Adjacent complexes are stabilized by interaction with
VP19C and VP23. If cleavage at the maturation site of 22a
and the UL26 gene product occurs prior to VP19C and
VP23 interactions, one would not observe capsid forma-
tion. Capsid shell precursors were not observed in ex-
tracts of cells infected with the VP19C null mutant. There-
fore, we wondered if precursors would form if the matu-
ration site of UL26 was also blocked in the VP19C null
mutant. To determine if this was the case we isolated a
double mutant virus following infection of C32 cells with
KD19C and KUL26-610/611. The double mutant was iden-
tified by growth on C32 cells, but not on cells that ex-
pressed either UL26 or UL38 gene products. The double
mutant virus was used to infect Vero cells in the pres-
ence of [35S]methionine and the nuclei were lysed and
sedimented through sucrose gradients, and fractions
examined by SDS–PAGE (data not shown). There was no
peak of radioactivity corresponding to capsid proteins in
any of the fractions. We conclude that the protease ac-
tivity present in null mutants of capsid proteins does not
preclude the formation of capsid precursors.
DISCUSSION
A cell line was isolated that supports the growth of null
mutant viruses in all of the essential capsid genes. It was
used to isolate a null mutant in the gene encoding VP19C
(UL38), a mutant virus blocked at the maturation cleav-
age site in UL26, and a virus encoding both mutations.
The null mutant virus, KD19C, did not form detectable
precursor structures as judged by sedimentation and
electron microscope analyses. We have now constructed
null mutant viruses in the three essential gene products
that comprise the capsid shell. These viruses encode
mutations that abrogate expression of VP5, VP23, or
VP19C and do not form detectable capsid precursor
structures by the sedimentation procedures used. We
conclude that the formation of capsid shells requires the
simultaneous presence of all three essential proteins
(VP5, VP19C, and VP23). It has also been reported that
capsid shells are formed when the components of the
capsid shell are present in a virus that encodes null
mutants in the protease (VP24) and scaffold (22a and 21)
(Desai et al., 1994). Therefore, capsid shells are formed
when all of the essential molecules are present and in
the absence of the protease and scaffold molecules.
However, these capsid shells sediment more rapidly
than B capsids, presumably because they form extended
sheets that lack the correct curvature of authentic B
capsids. Therefore, one of the functions of the scaffold is
to provide the correct curvature and/or closure of the
shell.
FIG. 8. The synthesis of the UL26 gene product by KUL26-610/611.
Vero cells were infected with KOS or the mutant virus and infected cell
lysates were prepared and run on 17% gels (SDS–PAGE). Proteins were
electroblotted onto nitrocellulose and probed with an antibody specific
to amino acids 8 to 14 of UL26. Results for mock-infected cells are
shown in lane 1 and for cells infected with KOS (lane 2) and KUL26-
610/611 (lane 3). A sample of B capsids from the KOS infections shown
in Fig. 7 was included and is designated B.
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In contrast to the results reported here, 70-nm struc-
tures that could correspond to capsid precursors have
been observed in insect cells infected with baculovi-
ruses that express UL19 (VP5) and UL38 (VP19C) gene
products (Rixon et al., 1996). In addition, Thomsen et al.
(1994) reported the formation of 50-nm particles when
baculoviruses were used that expressed VP5, VP19C,
and the scaffold protein, 22a, but the particles contained
only VP5 and VP19C. The particles observed in both
studies may result from the same molecular interactions
that occur between VP5 and VP19C during infection.
Infection of nonpermissive mammalian cells with the
K23Z mutant, which expresses VP5, VP19C, and the pro-
tease and scaffold molecules, did not form these struc-
tures, as noted in the last paragraph. The nuclear lysate
and sedimentation conditions employed were the same
as used by Thomsen et al. (1994) and by Rixon et al.,
(1996). We conclude that the particles formed in the
baculovirus system are not formed in infected mamma-
lian cells. Nevertheless, the interactions between VP5
and VP19C used to form the particles in infected insect
cells may occur at the same amino acid residues of the
two capsid proteins as are found when VP23 is also
present.
C32 cells were also used to isolate a mutant virus,
KUL26-610/611, that is altered at the maturation cleavage
site of UL26 (between amino acids 610 and 611). The
mutation was lethal and therefore required a cell line that
expressed UL26 for its propagation. The protease in the
mutant virus encoded by UL26 is active and cleaved the
gene product between the Ala and Ser residues at 247
and 248, to produce VP24 and 21, the N- and C-terminal
proteins, respectively. B capsid formation requires the
presence of the C-terminal residues of UL26, which are
known to interact with VP5, and B capsids are formed by
KUL26-610/611 during infection of Vero cells. The scaf-
fold proteins (22a and 21) in the B capsids are uncleaved.
C capsids that contain viral DNA are not formed so the
block in viral growth is at this stage of morphogenesis.
Interestingly, the N-terminal cleavage product of UL26,
VP24, normally a component of capsids and virions, is
not present or if present it is at a low copy number in the
B capsids. If, as is likely, VP24 was initially present in the
capsids, its retention is dependent on maturation site
cleavage and/or a conformation change that occurs after
cleavage.
The simplest model for B capsid formation is that VP5
pentamers and hexamers form (in combination with pro-
tease and scaffold molecules), and adjacent VP5 cap-
somers are held together by VP19C and VP23. The model
is based on the recent reports of capsid formation in vitro
using capsid proteins obtained from expression of indi-
vidual components from baculovirus-infected insect cells
(Newcomb et al., 1996) and on the role of VP19C and
VP23 in capsid formation from electron microscope re-
construction experiments (Trus et al., 1996). Capsid
growth is by accretion of the essential components on a
three-dimensional net. Newcomb et al. (1996) were able
to trace capsid formation from early spherical structures
to icosahedral forms found later during incubation of in
vitro extracts. It remains to be determined whether the
spherical to icosahedral transition occurs during virus
infections in mammalian cell culture.
MATERIALS AND METHODS
Cells and viruses
Vero cells and transformed cell lines were grown in
Eagle’s minimum essential medium supplemented with
10% fetal calf serum (GIBCO-BRL). Virus stocks were
prepared as previously described (Person et al., 1976).
C32 was used as the permissive cell line for the propa-
gation of mutant viruses. The viruses, A44 and the tem-
perature-sensitive (ts) mutant in VP19C, A44ts2, were
obtained from Dr. Peter Sheldrick, 94802 Villejuif, France
(Pertuiset et al., 1989).
Plasmids
The 1.4-kb UL38 ORF which specifies VP19C is en-
coded within a 3.9-kb BamHI/SalI fragment which was
obtained from the BamHI-H fragment of KOS DNA and
cloned into the same sites of pUC19 (pKUL38). The UL26
ORF, which specifies the protease (VP24) and scaffold
(21 and 22a) proteins, is encoded within a 3.9-kb FspI
fragment which was obtained from a UL26-encoding,
6.5-kb NotI plasmid (pKNot1, Desai et al., 1994) and
cloned into HincII-cleaved pUC19 (pKUL26). The UL18
and UL19 ORFs, which specify VP23 and VP5, respec-
tively, are encoded within a 7.2-kb KpnI/BglII fragment
obtained from the KpnI-I fragment and was cloned into
KpnI/BamHI sites of pUC19 (pKUL18-19). A plasmid
(pKDUL38) that was deleted for almost the entire UL38
ORF was derived from pKUL38. The deletion, 1.26 kb,
extended from a NruI site 15 bp upstream of the UL38
start codon to a BsiWI site 150 bp upstream of the stop
codon.
Construction of transformed Vero cell lines
The procedure of DeLuca et al. (1985) was followed for
transformation of Vero cells. Subconfluent monolayers of
Vero cells (2 3 106) in 100-mm petri dishes were cotrans-
fected with pSV2neo (2.0 mg) and plasmids pKUL18-19
(15 mg), pKUL26 (4 mg), and pKUL38 (8 mg) using the
calcium phosphate precipitation procedure. At 24 h after
transfection the cells were harvested and plated at a
density of 4 3 105 cells per 100-mm dish in medium
containing 1 mg/ml G418 (GIBCO-BRL). The medium was
replenished every 3 days. G418-resistant colonies were
harvested using perspex cloning chambers (Bellco
Glass) and tested for their ability to support the replica-
tion of null mutant viruses in each essential capsid gene.
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Marker transfer of null mutations
Subconfluent monolayers of cells (1 3 106) in 60-mm
dishes were cotransfected with 1 mg linearized plasmid
and approximately 5 mg of KOS genomic DNA extracted
from crude virion preparations as described previously
(Desai et al., 1993). Approximately 48 h after transfection
the cell monolayers were harvested, freeze/thawed
once, and sonicated and total virus progeny was titered.
Southern blot hybridization
DNA sequences were detected after agarose gel elec-
trophoresis by Southern blot analysis, using random-
primer-labeled probes (Boehringer-Mannheim), labeled
with [a-32P]deoxycytidine 59-triphosphate (DuPont-NEN).
Fragment sizes in Southern blot experiments were de-
termined from the mobilities of DNA markers that were
measured prior to blotting of fragments.
Radiolabeling, immunoprecipitation, and SDS–PAGE
Radiolabeling of KD19C-infected cells was carried out
using preformed monolayers (1 3 106 cells) in six-well
trays (35-mm-diameter well). Infected cell monolayers
were rinsed twice with tricine-buffered saline (TBS) (Per-
son et al., 1976) and overlaid with methionine-free Dul-
becco’s modified Eagle’s medium (GIBCO-BRL) contain-
ing 100 mCi of [35S]methionine (DuPont-NEN). The cells
were lysed in 1.0 ml RIPA buffer (50 mM Tris, pH 7.2, 150
mM NaCl, 1% Na deoxycholate, 1% SDS, 1% Triton X-100)
plus 0.5 mM tosyllysylchloromethyl ketone (TLCK). Ly-
sates were clarified by centrifugation. For immunopre-
cipitation of proteins, 250 ml of the lysate was combined
with 3 ml of antibody and incubated overnight at 4°C. The
next day 50 ml of protein A–Sepharose beads (Sigma)
swollen in RIPA buffer was added to the tube and incu-
bated for 2 h at 4°C with continuous rotation. The beads
were washed five times with RIPA buffer and resus-
pended in 25 ml 23 Laemmli sample buffer. Samples (10
ml) were boiled prior to electrophoresis. Sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
analyses were performed using the mini-protean gel
system (Bio-Rad). Gels were cast according to the pro-
tocol supplied by the manufacturer, except that N,N9-
diallytartardiamide (DATD) was the cross-linking agent.
Gels were treated to ENhance (DuPont-NEN) and dried
prior to autoradiography.
Western blots
Confluent monolayers of cells (1 3 106 cells) were
infected with virus at a multiplicity of infection (m.o.i.) of
10 PFU/cell and harvested 24 h after infection. Proteins
were separated on 12% acrylamide SDS–PAGE and
transferred to NYTRAN (Schleicher & Schuell) according
to procedures supplied by the manufacturer (Bio-Rad).
Filters were blocked with 1% BLOTTO in TN buffer (10
mM Tris, pH 7.4, 150 mM NaCl, 0.2% sodium azide) and
exposed to VP19C antibody (NC2) for 90 min, washed
extensively, exposed to [125I]-labeled protein A (DuPont-
NEN) for 60 min, washed, and air dried prior to autora-
diography. Antibodies and washes were in TN buffer.
Antibodies prepared against VP19C were provided by
Drs. R. Eisenberg and G. Cohen (University of Pennsyl-
vania). Peptide antibodies specific to amino acids 8 to 14
of UL26 (antibody 37-94) were generously provided by
Dr. R. LaFemina (Merck Research Laboratories). Peptide
antisera specific to residues 611–635 of UL26 (UL26-C)
were prepared in rabbits by Research Genetics Inc.
Sedimentation analysis
Confluent monolayers of Vero cells in two 100-mm
diameter petri dishes (approximately 1 3 107 cells) were
infected at an m.o.i. of 10 PFU/cell. After adsorption, 4 ml
of labeling medium was added to each culture. Labeling
medium consists of 70% Dulbecco’s MEM medium with-
out methionine, 20% F12 (contains 5 mg/ml of methionine
and 10% fetal bovine serum (GIBCO-BRL)). Eight hours
after infection, 200 mCi of [35S]methionine (DuPont-NEN)
was added to each culture and incubation continued
until 24 h postinfection. Cells were scraped into the
growth medium, and cultures from duplicate plates were
combined and pelleted at 3500 g for 5 min at 4°C. Pellets
were resuspended in TBS, pelleted again, resuspended
in 0.53 capsid lysis buffer (500 mM NaCl, 20 mM Tris, pH
7.5, 1 mM EDTA, pH 8.0, 1% Triton X-100, and 0.5 mM
TLCK), and left on ice for 5 min and the nuclei pelleted by
centrifugation at 3500 g for 15 min at 4°C. Nuclei were
lysed in 23 capsid lysis buffer and sonicated and the
lysate was layered onto a 20 to 50% sucrose gradient
(w/v in 300 mM NaCl, 20 mM Tris, pH 7.5, 1 mM EDTA, pH
8.0, and 0.5 mM TLCK) and centrifuged at 24,000 rpm for
120 min in a Beckman SW41 rotor at 4°C. Fractions were
collected and radioactivity determined by liquid scintilla-
tion counting. For SDS–PAGE analysis fractions were
precipitated with equal volumes of 10% trichloroacetic
acid.
Oligonucleotide-directed in vitro mutagenesis
Mutagenesis employed the Muta-Gene phagemid kit
supplied by Bio-Rad. The KpnI-T fragment, encoding
UL26, was cloned into the same site in the pTZ19U vector
which includes the single-strand origin of replication of
the bacteriophage f1. The plasmid was transfected into a
uracil repair-deficient bacterium (CJ236) and superin-
fected with helper phage R408 (Russel et al., 1986) to
yield a large proportion of phage whose single-stranded
DNA contains uracil residues at a limited number of
thymine sites. This DNA was used as template during
the oligonucleotide-directed in vitro mutagenesis reac-
tion. Following synthesis the double-stranded DNA was
transformed into the uracil repair-proficient strain (DH5a)
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which results in inactivation of uracil containing DNA in
the parental stand.
Electron microscopy
Confluent monolayers of infected cells were fixed in
4% formaldehyde, 2% glutaraldehyde in 0.1 M phosphate
buffer (pH 7.2). The samples were then postfixed in 1%
osmium tetroxide, stained with uranyl acetate, dehy-
drated through a graded series of ethanols, and embed-
ded in Polybed 812 resin. Thin sections were cut at 0.1
mm in a Porter Blum MT-1 ultramicrotome, mounted on
carbon-coated grids, stained with lead citrate and uranyl
acetate, and examined at 60 kV under a JOEL 1200EX
electron microscope.
Data preparation
Autoradiographs were scanned on a Umax Powerlook
II scanner. The images were scanned at 300 dots per
inch into Adobe Photoshop 3.0 and were transported as
PICT files into Microsoft Powerpoint for figure presenta-
tion and printing.
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